Osteocentric Ditches Integrum Acquisition, Stock Plummets

Medtech Magazine reports that Osteocentric has withdrawn its planned acquisition of Integrum, a Gothenburg-based developer of prosthetics. This announcement led to a significant drop in Integrum's stock price in early trading. The original offer, made in late July, valued Integrum at 939 million SEK and included a 124 percent premium. The acquisition was contingent on shareholder approval for more than 90 percent of the company's shares, which would have enabled Osteocentric to commence a compulsory acquisition of the remaining stock.